Insights into the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices and Equipment Global Market to 2022 - Identify Growth Segments for Investment - ResearchAndMarkets.com

DUBLIN--()--The "Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.

The global benign prostatic hyperplasia (BPH) treatment devices and equipment market was valued at about $0.9 billion in 2018 and is expected to grow to $1.13 billion at a CAGR of 5.9% through 2022.

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global benign prostatic hyperplasia (BPH) treatment devices and equipment market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

The benign prostatic hyperplasia (BPH) treatment devices and equipment market consists of sales of benign prostatic hyperplasia (BPH) treatment devices and equipment and related services. Benign prostatic hyperplasia or benign prostatic hypertrophy is a condition of an enlarged prostate gland which causes blockade of urethra, the tube that carries urine from the bladder. The market is segmented into resectoscopes, radiofrequency ablation device, urology lasers, prostatic stents and implants.

The side effects suffered by the patients after a BPH procedure is one of the major restraints for BPH device and equipment market. For example, most common side effects of a BPH surgery includes, urinary incontinence, discomfort during urination and difficulty in completely emptying the bladder. The patients suffering from BPH does not prefer surgical procedures (till the stage it can be avoided) due to these side effects, therefore decreasing the demand of surgical procedures, which in turn limits the demand for devices used by end users like hospitals, clinics and ambulatory surgical centers.

Prostatic Astery Embolization (PAE) is one of the latest developments in the market for Benign Prostatic Hyperplasia (BPH) treatment device and equipment. PAE is a minimally invasive treatment that assists in reducing the symptoms observed in urinary tract. The PAE procedure is done using X-rays and other advanced imaging to observe the tumor inside the body and accordingly treat it without any surgery. This technique results in reduced complication in the treatment of BPH and thus is said to be a major development in the market of BPH treatment. Leading companies such as Boston scientifics, UNC healthcare, and Spire healthcare have been investing in the market for PAE.

Key Topics Covered:

1. Executive Summary

2. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Characteristics

3. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Size And Growth

3.1. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Historic Market, 2015 - 2019, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Segmentation

4.1. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

  • Resectoscopes Radiofrequency ablation device
  • Urology lasers Prostatic Stents
  • Implants

4.2. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

  • Hospitals Ambulatory Surgical Centres (ASC)
  • Clinics Home

4.3. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Segmentation By Procedure Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

  • Transurethral Needle Ablation (TUNA) Transurethral Resection of Prostate (TURP)
  • Transurethral Incision of Prostate (TUIP) Transurethral microwave thermotherapy (TUMT)
  • Laser surgery Others

5. Benign Prostatic Hyperplasia Treatment Devices and Equipment Market Regional And Country Analysis

5.1. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

5.2. Global Benign Prostatic Hyperplasia Treatment Devices and Equipment Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

Companies Mentioned

  • Karl Storz
  • Lumenis
  • Olympus
  • Urologix
  • Boston scientific Inc.
  • Endo International
  • Neo tract
  • Lisa Laser (U.S.)
  • Medifocus Inc. (Canada)
  • ProArc Medical LTD. (Israel)
  • Olympus America
  • Teleflex
  • Medtronic
  • Urotech
  • Prostalund Operations AB
  • Baxter International
  • NxThera
  • Richard Wolf GmbH
  • Coloplast A/S
  • Siemens
  • Quest Pharmatech
  • Protox Therapeutics
  • IntelGenx Technologies Corp
  • Astellas Pharma Inc.
  • Ipsen S.A.

For more information about this report visit https://www.researchandmarkets.com/r/ajmj0b

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900